Skip to main content
Premium Trial:

Request an Annual Quote

Nobel Cash Flow

The Nobel Foundation, which just finished its weeklong string of awarding its prizes, is some financial issues, Bloomberg reports. The foundation, which had turned to hedge fund investments, may soon be now looking for charitable donations, Bloomberg adds, as it took a hit in those markets.

Bloomberg calculates that "[r]elying on hedge funds over standard equity indexes over the past year would have resulted in relative losses," though the foundation did not disclose which hedge funds it participates in.

In addition, the foundation last year slimmed down the size of the awards given to laureates by 20 percent to 8 million kronor, or about $1.23 million. It is also scaling the awards banquet back, again by about 20 percent.

"There is a long-term problem if we want to raise the ambition level, which I'd like to see us do," Lars Heikensten, executive director of the Nobel Foundation, tells Bloomberg. "It'll be difficult to save more and it will also be difficult to maintain costs at the current level. This indicates there will be a need for more money over time."

Heikensten adds that the foundation isn't yet looking for donations, but is exploring that possibility for the future to " "help beef up our capital."

And as Gawker notes, surely they know a few good economists?

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.